Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients. [electronic resource]
Producer: 20071203Description: 366-72 p. digitalISSN:- 0168-8278
- Adenine -- analogs & derivatives
- Adult
- Antiviral Agents -- therapeutic use
- Cohort Studies
- DNA, Viral -- blood
- Drug Resistance, Viral
- Female
- Gene Dosage
- Genotype
- Hepatitis B Antibodies -- blood
- Hepatitis B e Antigens -- blood
- Hepatitis B virus -- genetics
- Hepatitis B, Chronic -- drug therapy
- Humans
- Lamivudine -- therapeutic use
- Male
- Middle Aged
- Organophosphonates -- therapeutic use
- Predictive Value of Tests
- Retrospective Studies
- Reverse Transcriptase Inhibitors -- therapeutic use
- Sex Factors
- Time Factors
- Treatment Outcome
- Viral Load
- Virus Replication -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.